Tag Archives: pixantrone

No Light at The End of Tunnel

Posted on March 22, 2010 by admin

Cell Therapeutics (CTIC.O) suffered a setback on Monday as a U.S. advisory panel said the company had not collected enough data to win clearance for an experimental lymphoma drug. Today was the doom day for may CTIC  investors.  Two decade … Continue reading →

Posted in Biotech Stock | Tagged , , , , | 1 Comment

CTIC Gets New FDA Date

Posted on March 1, 2010 by admin

New FDA date for reviewing pixantrone of Cell Therapeutics is March 22. The earlier scheduled meeting was cancelled due to severe winter weather in February. Continue reading →

Posted in Biotech Stock, FDA News | Tagged , , , , | Leave a comment